Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Pack Size Compliance Study
NCT01817777Phase 4Terminated
- Sponsor
- GSK
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by GSK. Primary endpoint: Change From Baseline in HbA1c Values at 28 weeks. Started May 2013; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01817777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817777.